Zobrazeno 1 - 10
of 637
pro vyhledávání: '"Céleste Lebbé"'
Autor:
Jérémie Delaleu, Maxime Battistella, Caroline Ram‐Wolff, Hélène Moins‐Teisserenc, Van‐Anh Ta, Marie Roelens, Jacqueline Rivet, Céleste Lebbé, Samia Mourah, Baptiste Louveau, Jean‐David Bouaziz, Martine Bagot, Adèle deMasson
Publikováno v:
JEADV Clinical Practice, Vol 3, Iss 2, Pp 668-671 (2024)
Abstract Cutaneous T‐cell lymphomas (CTCLs) are unique non‐Hodgkin lymphomas due to the proliferation of skin‐homing T cells. Sezary syndrome (SS), a subtype of CTCL, typically presents as erythroderma with specific blood involvement and seldom
Externí odkaz:
https://doaj.org/article/8de2d473bd5b431384f8c77f693817a3
Autor:
David Russo, Stéphane Dalle, Olivier Dereure, Laurent Mortier, Sophie Dalac-Rat, Caroline Dutriaux, Marie-Thérèse Leccia, Delphine Legoupil, Henri Montaudié, Eve Maubec, Julie De Quatrebarbes, Jean-Philippe Arnault, Florence Granel Brocard, Philippe Saïag, Brigitte Dreno, Clara Allayous, Bastien Oriano, Wendy Lefevre, Céleste Lebbé, Lise Boussemart
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundThe tumor mutational burden (TMB) is high in melanomas owing to UV-induced oncogenesis. While a high TMB is a predictive biomarker of response to PD-1 inhibitors, it may be associated with the rise of resistant clones to targeted therapy ov
Externí odkaz:
https://doaj.org/article/f844a1fc7d06416ea3d2882e024c7f02
Autor:
Diaddin Hamdan, Charlotte Gardair, Frédéric Pamoukdjian, Marie-Noëlle Peraldi Gardin, Inès Nakouri, Christophe Leboeuf, Anne Janin, Céleste Lebbé, Maxime Battistella, Guilhem Bousquet
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 2, p 1147 (2024)
Cutaneous squamous cell carcinomas in kidney-transplant recipients are frequent, with an increasing incidence linked to long immunosuppression durations and exposure to ultraviolet radiation. p53 is at the cornerstone of ultraviolet-induced DNA damag
Externí odkaz:
https://doaj.org/article/270b246a6ec54e4398c2ef6244d7bb1e
Autor:
Julie Delyon, Anaïs Vallet, Mélanie Bernard-Cacciarella, Isabelle Kuzniak, Coralie Reger de Moura, Baptiste Louveau, Fanélie Jouenne, Samia Mourah, Céleste Lebbé, Nicolas Dumaz
Publikováno v:
Cancers, Vol 15, Iss 11, p 2888 (2023)
Because BRAF-mutated melanomas are addicted to the Mitogen Activated Protein Kinase (MAPK) pathway they show a high response rate to BRAF and MEK inhibitors. However, the clinical responses to these inhibitors are often short-lived with the rapid ons
Externí odkaz:
https://doaj.org/article/9fa529c6951d44579b7cafcac78fb957
Autor:
Yohan Fayet, Raphaël Tétreau, Charles Honoré, Louis-Romée Le Nail, Cécile Dalban, François Gouin, Sylvain Causeret, Sophie Piperno-Neumann, Simone Mathoulin-Pelissier, Marie Karanian, Antoine Italiano, Loïc Chaigneau, Justine Gantzer, François Bertucci, Mickael Ropars, Esma Saada-Bouzid, Abel Cordoba, Jean-Christophe Ruzic, Sharmini Varatharajah, Françoise Ducimetière, Sylvie Chabaud, Pascale Dubray-Longeras, Fabrice Fiorenza, Sixtine De Percin, Céleste Lebbé, Pauline Soibinet, Paul Michelin, Maria Rios, Fadila Farsi, Nicolas Penel, Emmanuelle Bompas, Florence Duffaud, Christine Chevreau, Axel Le Cesne, Jean-Yves Blay, François Le Loarer, Isabelle Ray-Coquard
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-12 (2021)
Abstract Background Spatial inequalities in cancer management have been evidenced by studies reporting lower quality of care or/and lower survival for patients living in remote or socially deprived areas. NETSARC+ is a national reference network impl
Externí odkaz:
https://doaj.org/article/960c624c4511448d9bb376af5c4e574b
Publikováno v:
Cancers, Vol 15, Iss 3, p 872 (2023)
Kaposi’s sarcoma (KS) is a common neoplasm in Eastern and central Africa reflecting the spread of human gammaherpesvirus-8 (HHV-8), now considered a necessary causal agent for the development of KS. The endemic KS subtype can follow an aggressive c
Externí odkaz:
https://doaj.org/article/53851a58d5da4b8189b39675c9659108
Autor:
Coralie Reger de Moura, Laetitia Vercellino, Fanélie Jouenne, Barouyr Baroudjian, Aurélie Sadoux, Baptiste Louveau, Julie Delyon, Kevin Serror, Lauriane Goldwirt, Pascal Merlet, Fanny Bouquet, Maxime Battistella, Céleste Lebbé, Samia Mourah
Publikováno v:
Translational Oncology, Vol 13, Iss 2, Pp 275-286 (2020)
The development of BRAF and MEK inhibitors (BRAFi/MEKi) has led to major advances in melanoma treatment. However, the emergence of resistance mechanisms limits the benefit duration and a complete response occurs in less than 20% of patients receiving
Externí odkaz:
https://doaj.org/article/3c608e0fc0b044eab9dd9e6fd7ebe3ad
Autor:
Anne Zaremba, Rafaela Kramer, Viola De Temple, Stefanie Bertram, Martin Salzmann, Anja Gesierich, Lydia Reinhardt, Barouyr Baroudjian, Michael M. Sachse, Gunhild Mechtersheimer, Douglas B. Johnson, Alison M. Weppler, Lavinia Spain, Carmen Loquai, Milena Dudda, Claudia Pföhler, Adriana Hepner, Georgina V. Long, Alexander M. Menzies, Matteo S. Carlino, Céleste Lebbé, Tomohiro Enokida, Makoto Tahara, Paul J. Bröckelmann, Thomas Eigentler, Katharina C. Kähler, Ralf Gutzmer, Carola Berking, Selma Ugurel, Nadine Stadtler, Antje Sucker, Jürgen C. Becker, Elisabeth Livingstone, Friedegund Meier, Jessica C. Hassel, Dirk Schadendorf, Maher Hanoun, Lucie Heinzerling, Lisa Zimmer
Publikováno v:
Frontiers in Oncology, Vol 11 (2021)
IntroductionImmune checkpoint inhibitors (ICI) are increasingly being used to treat numerous cancer types. Together with improved recognition of toxicities, this has led to more frequent identification of rare immune-related adverse events (irAE), fo
Externí odkaz:
https://doaj.org/article/d10a83d504ce49babdcbd1b891ef629b
Autor:
Alexia Rivas, Julie Delyon, Antoine Martineau, Estelle Blanc, Clara Allayous, Laetitia Da Meda, Pascal Merlet, Céleste Lebbé, Barouyr Baroudjian, Laetitia Vercellino
Publikováno v:
Cancers, Vol 14, Iss 13, p 3190 (2022)
Background: Immune checkpoint inhibitors (ICI) are currently the first-line treatment for patients with metastatic melanoma. We investigated the value of positron emission tomography (PET) response criteria to assess the therapeutic response to first
Externí odkaz:
https://doaj.org/article/be4086d9fccd4e61b21923bacf9167cc
Autor:
Hélène Mascitti, Adèle De Masson, Florence Brunet-Possenti, Jean-David Bouaziz, Pauline Laly, Nadim Mourad, Jean-Michel Garrigues, Sara Laurent-Roussel, Bénédicte Cavelier-Balloy, Isabelle Moulonguet, Cristina Leschi, Samia Mourah, Martine Bagot, Céleste Lebbé, Nicole Basset-Seguin
Publikováno v:
Dermatology and Therapy, Vol 9, Iss 2, Pp 383-388 (2019)
Abstract Introduction Keratoacanthomas (KA) are common cutaneous skin tumors originating from the hair follicles. Unlike squamous cell carcinoma, KA can regress spontaneously and have a benign evolution. Solitary KA is the most common form but famili
Externí odkaz:
https://doaj.org/article/a68ccc68eedf40f395d33e0110b20d55